APOBEC3G antibody (Apolipoprotein B MRNA Editing Enzyme, Catalytic Polypeptide-Like 3G) (N-Term)

Details for Product anti-APOBEC3G Antibody No. ABIN965574, Supplier: Log in to see
Antigen
  • A3G
  • ARCD
  • ARP-9
  • ARP9
  • CEM-15
  • CEM15
  • bK150C2.7
  • dJ494G10.1
  • apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
  • APOBEC3G
Epitope
N-Term
45
33
15
15
11
8
8
6
4
3
2
2
2
1
1
1
1
1
1
1
1
Reactivity
Human
173
7
4
2
Host
Rabbit
138
24
11
Clonality
Polyclonal
Conjugate
This APOBEC3G antibody is un-conjugated
10
10
10
9
9
9
1
1
1
1
1
1
1
1
1
1
1
Application
Immunohistochemistry (IHC)
143
94
73
30
13
11
4
3
1
1
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Immunogen Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to N-terminal residues of human APOBEC3G (apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3G)
Alternative Name APOBEC3G (APOBEC3G Antibody Abstract)
Background APOBEC3G (apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3G) is a member of the cytidine deaminase gene family. It is one of seven related genes or pseudogenes found in a cluster, thought to result from gene duplication, on chromosome 22. Members of the cluster encode proteins that are structurally and functionally related to the C to U RNA-editing cytidine deaminase APOBEC1. APOBEC3G is thought that the proteins may be RNA editing enzymes and have roles in growth or cell cycle control. APOBEC3G has been found to be a specific inhibitor of human immunodeficiency virus-1 (HIV-1) infectivity.
Research Area Immunology, Chromatin Binding Proteins
Restrictions For Research Use only
Product cited in: Pido-Lopez, Jeffrey, Wang, Seidl, Babaahmady, Vaughan, Lehner: "The effect of allogeneic in vitro stimulation and in vivo immunization on memory CD4(+) T-cell APOBEC3G expression and HIV-1 infectivity." in: European journal of immunology, Vol. 39, Issue 7, pp. 1956-65, 2009 (PubMed).

Chen, He, Wang, Xu, Yu: "A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G." in: Journal of virology, Vol. 83, Issue 17, pp. 8674-82, 2009 (PubMed).

Dang, Wang, Zhou, York, Zheng: "Identification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization." in: Journal of virology, Vol. 83, Issue 17, pp. 8544-52, 2009 (PubMed).

Vetter, DAquila: "Cytoplasmic APOBEC3G restricts incoming Vif-positive human immunodeficiency virus type 1 and increases two-long terminal repeat circle formation in activated T-helper-subtype cells." in: Journal of virology, Vol. 83, Issue 17, pp. 8646-54, 2009 (PubMed).

Kamada, Igarashi, Martin, Khamsri, Hatcho, Yamashita, Fujita, Uchiyama, Adachi: "Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, Issue 45, pp. 16959-64, 2006 (PubMed).